Translational Advances in Gynecologic Cancers Translational Advances in Gynecologic Cancers

Translational Advances in Gynecologic Cancers

    • $189.99
    • $189.99

Publisher Description

Translational Advances in Gynecologic Cancers straddles the bench and bed divide by highlighting important and interesting research that is translatable to the clinic. The contents of this book cover the entire spectrum, from promising laboratory based research, to clinical trial efforts. Further, new therapeutic indications based upon randomized phase III trials are also included.

Clinicians will learn about lab-based science that is about to enter the clinic, along with the rationale behind translational endpoints in trials. Researchers will be able to identify and understand the clinical needs of patients with these types of tumors to improve their research focus.



- Provides a comprehensive description of all evolving translational gynecologic cancer research for clinicians

- Identifies knowledge gaps to inform the next research direction

- Ties together clinical research and patient needs to help both the researcher and clinician

- Addresses genomics, new target therapies, novel tools, and more for ovarian, endometrial, and cervical cancer

GENRE
Science & Nature
RELEASED
2017
25 January
LANGUAGE
EN
English
LENGTH
354
Pages
PUBLISHER
Academic Press
SELLER
Elsevier Ltd.
SIZE
25.9
MB
Cancer Metastasis Cancer Metastasis
2011
Carcinogenicity Carcinogenicity
2021
Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer Monoclonal Antibody and Peptide-Targeted Radiotherapy of Cancer
2010